Matthias Frick

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

Wolfgang Dichtl, Józef Dulak, Matthias Frick et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 342 citations · Full text

Medicine, Molecular Biology, Pharmacology +16

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance

Gerhard Poelzl, Michael Ess, Christine Mussner‐Seeber et al. · European Journal of Clinical Investigation · 2011 · 206 citations

Medicine, Cardiology, Internal Medicine +16

Heme Oxygenase Activity Modulates Vascular Endothelial Growth Factor Synthesis in Vascular Smooth Muscle Cells

Józef Dulak, Alicja Józkowicz, Roberta Foresti et al. · Antioxidants and Redox Signaling · 2002 · 182 citations

Life Sciences, Biochemistry, Cell Biology +17

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17